Anti-Cancer Agent Stops Metastasis In Its Tracks
Anomalyst writes "Mice were implanted with cancer. The control group died as tumors metastasized. The experimental group was treated with macroketone and survived a normal lifespan. While the cancer was not cured, metastasis was significantly (over 80%) inhibited. Even after metastasis had begun and additional cancers developed, macroketone inhibited subsequent metastasis. The original article is in Nature behind a paywall."
This post is a thank you for your contribution. It is heartfelt.
Cancer is bad. Implanting cancer into mice is bad for the mice. But it is good for humans.
Because we hate mice.
Since the side effects don't appear to significantly increase mortality this should obviously be given an immediate fastrack for human trials and should get to Phase III ASAP.
There are 4 boxes to use in the defense of liberty: soap, ballot, jury, ammo. Use in that order. Starting now.
You don't sell your research to Nature. You submit it for publication and are overjoyed if they accept it. Nature is the most prestigious publication in the field of biology bar none.
But as far as I know, theres nothing stopping you from putting it up on your web site as well or submitting it in publication in other journals.
So it being published in Nature doesnt stop it from being publically available. Its just that the other copies might be harder to find..
Researches don't get paid for publishing, some journals even require them to pay "page charges" to get their work published.
Paywalls aren't an issue because most people will not be able to understand scientific articles of this complexity. Those that would understand it already have access via their university or company. Science is reported to the public in news articles such as the one linked which has the benefit of glossing over the technical details and summarising the findings very well, something that can be extremely difficult to do by reading the paper itself.
The issue for researchers is recognition. The more recognition, the more funding they will be able to get in the future. And the best place to get recognition is high impact factor journals like Nature and Science. Open access journals have nowhere near as much impact factor.
Stop talking like a seditious teabagger. The government only has our best interest at heart and we certainly aren't smart enough to make these kinds of decisions for ourselves.
Yes. If you are not doing scientific research why are you trying to read science articles, drone? Get back to work and stop thinking about things.
Pulp Audio Weekly - Geek News and Reviews
Sorry, you're wrong. I work in FDA compliance so I happen to know a little more about this subject. There are PLENTY of provisions in the CFR (Code Federal Regulations) governing use of experimental or not fully tested drugs on terminally ill patients. Look up "Compassionate Use". A miracle drug that saves 1/3 of hospice patients from cancer would certainly be funded by a biotech/pharma company or the US government. But guess what, drugs cannot under any circumstances go to large-scale populations because if they are untested, you will end up killing more people than you save. In your example, sure the drug may have saved 1/3 of hospice patients, but it very well could have caused the other 2/3 of them to die faster, or suffer a stroke, or whatever. Unless these risks are known, its completely irresponsible for the government to allow it to go into widespread use without a proper clinical trial. There are very valid reasons to the FDAs laws governing drugs. There is no evil boogyman that is trying to prevent miracle drugs from coming to market.
Welcome to Green Scientific Experiments Ltd.
Thanks to our Mice and Other Animals Recycling -MOAR (TM), we enable laboratories to save thousands of mice around the world, helping them to reuse mice across experiments.
Done with the Infect(*), Let die, Dissect cycle, you can now use the moar efficient cycle: Infect, Cure, Analyze, REpeat ! (I CARE) (**).
Call us today for a discount and get 10 (recycled) mice as gift.
(*) currently MOAR only works against some types of cancers. We're working on a second generation solution allowing to work against other types of laboratory deadly experiments such as virus, radiation exposure, etc.
(**) even if MOAR enables you to reuse mice ad vitam æternam, we advice our clients to not reuse them moar than 10 times due to psychological side effects. To end the I CARE cycle in a green and respectful manner, we work in cooperation with reptilariums across the world to help you fully recycle your mice.
Sneak teach kids Algebra using a game
drugs cannot under any circumstances go to large-scale populations because if they are untested, you will end up killing more people than you save
This is where you are wrong. You have one fact. The fact that this drugs cures 1/3 of the people taking it in the tests.
You do not have the fact that it kills any one. You just think it could. If we are talking about terminal cancer patients, they should be given it.
Also, even if the drug do kill people, it can be a risk worth taking. Lets say that this drug is tested in a group of people with late stage cancer and an average six months to die. Even if the drug kills 2 out of 3, but it cures 1 out of 3, it is a risk I would take. I would happily accept the risk of an "early" dead if I would get a chance to get cured.
In my mind it is morally wrong for the government to tell me that I can't make an informed decision with the information at hand and take the drug.
When his defense asked, "Which computer has Jon Johansen trespassed upon?" the answer was: "His own."
'But as far as I know, theres nothing stopping you from putting it up on your web site as well or submitting it in publication in other journals.'
Nature has exclusive publication rights for the first 6 months, after which you're free to submit the paper to a public repository or put it up on your own site:
http://www.nature.com/authors/editorial_policies/license.html
This is rather more enlightened than some other major journals, which still require a copyright transfer to the publisher, but obviously falls short of full open access from day 1. But I think most people who get a paper in Nature will happily accept this compromise! (at least for now).
Incidentally, some form of open access is pretty much being forced on traditional publishers by major funding bodies, which now commonly require that most or all funded publications are submitted to journals that provide this (time delays are generally allowed), e.g.:
http://publicaccess.nih.gov/
http://science.cancerresearchuk.org/gapp/terms/openaccess_ukpmc/
So things are at least moving in the right direction.
Ideally, Drug companies would love it if they can make Cancer manageable instead of curing. Look at Diabetes.... its manageable.... meaning the patient spends thousands to stay alive but never gets cured.
Where is the profit in a cure.
A joke comes to mind,
Back when trades were handed from Father to Son; A son proudly proclaims to his dad, "Dad I cured the wonman who had been coming to you for 20 years and yet you couldn't cure her". Dad replies, "You fool, she was our only faithful customer".